LE WE PMID CA
Lung and bronchial system (Neoplasia)1650Lunge und Bronchialsystem (Neubildung)

Antineoplastic agents (Resistance)

Arthritis (rheumatoid)

Asbestos

Bacillus calmette guerin

Bartonella henselae

Bortezomib ttProteasom

BRG1 SMARCA4

Bronchioloalveolar carcinoma

Bronchoscopy (BASKET)

Calcium (Hypercalciemia)

Candida (BASKET)

Carney s complex

Caspase9b

Cdh1

Cetuximab ttEGFR

Chemoprevention

Chromoendoscopy

Cisplatin

Coccidioidomycosis

COPD

Crohn s disease

Cryptococcosis

Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia

Endotoxin

Erlotinib ttEGFR

Fat necrosis subcutaneous of the newborn

Gastrointestinal stromal cell tumor GIST

Gefitinib ttEGFR

Haemophilus influenzae

Histoplasmosis

IGFBP3

Langerhans cell histiocytosis

Lepra

Lipidomics

Liver (Diseases)

LKB1

Lung (CT)

Lung (Diseases interstitial)

Lung (Lipoid pneumonia)

Lung (Neoplasia epitheloid haemangioendothelioma)

Lung (Neoplasia Pulmonary blastoma)

Lung (Resection)

Lung (Toxicology)

Lung and bronchial system (Neoplasia)

Lymphoma (BASKET)

Lymphoma (Hodgkin)

Mesothelioma

Mycobacterium avium

Nedaplatin

Neoplasia (Carcinogenesis)

Neoplasia (Radiofrequency ablation)

Neuroendocrine System (Neoplasia Carcinoid)

Neuroendocrine system (Neoplasia)

Osteoarthritis

Ovary (Neoplasia)

Paracoccoidomycosis

Pemetrexed

Photodynamic oncologic treatment

Pleura (Neoplasia)

Pneumocystis carinii Pneumocystis jirovicii

Polymyositis

Pro gastrin releasing peptide

Proteasome (BASKET)

Pseudolymphoma (Lymphomatoid granulomatosis)

Pseudolymphoma (Plasma cell granuloma)

Pulmonary pleomorphic carcinoma

Radiation therapy

RNA (MicroRNA)

Sarcoidosis

Silicone

Slack skin disease

Stomach (Neoplasia)

SWI SNF

Testis (Neoplasia Seminoma)

Testis (Neoplasia)

Thorax (CT)

Thorax (Video assisted thoracoscopy)

Tomosynthesis

Topotecan

Tuberculosis

Vandetanib

Vinflunine

Wegener s granulomatosis

2009  
1
Tools used in the diagnosis and staging of lung cancer: what's old and what's new?
[19372092] QJM 102(7): 443-8 (2009)
2009  
2
Lung cancer: current diagnosis and treatment.
[20038979] Dtsch Arztebl Int 106(49): 809-18; quiz 819-20 (2009)
2008  
3
Adjuvant chemotherapy after complete resection of non-small cell lung cancer.
[19629205] Dtsch Arztebl Int 105(14): 249-54 (2008)
2008  
4
Complete mediastinal lymphadenectomy: the core component of the multidisciplinary therapy in resectable non-small cell lung cancer.
[18457958] Eur J Cardiothorac Surg 34(1): 187-95 (2008)
2004  
5
Surgical treatment of Pancoast tumours.
[15201002] Eur J Cardiothorac Surg 26(1): 202-8 (2004)
2003  
6
Pulmonary large-cell neuroendocrine carcinoma (LCNEC).
[12694759] Eur J Cardiothorac Surg 23(4): 457-60 (2003)
2000  
7
Long-term outcome after resection for bronchial carcinoid tumors.
[10925223] Eur J Cardiothorac Surg 18(2): 156-61 (2000)
2000  
8
Mucoepidermoid bronchial tumors: a review of 34 operated cases.
[10814920] Eur J Cardiothorac Surg 17(5): 566-9 (2000)
1998  
9
Localized fibrous tumours of the pleura: 15 new cases and review of the literature.
[9860200] Eur J Cardiothorac Surg 14(5): 453-9 (1998)
1993  
10
Diagnosis and treatment of bronchial carcinoid tumors: clinical and pathological review of 120 operated patients.
[8431307] Eur J Cardiothorac Surg 7(1): 8-11 (1993)
1993  
11
1990  
12
Pulmonary hamartoma. A clinical study of 77 cases in a 21-year period and review of literature.
[2407277] Eur J Cardiothorac Surg 4(1): 15-8 (1990)
2009  
13
EGFR targeted therapy in non-small cell lung cancer: potential role of cetuximab.
[19707410] Biologics 3(-): 215-24 (2009)
2007  
14
Review of erlotinib in the treatment of advanced non-small cell lung cancer.
[19707304] Biologics 1(4): 335-46 (2007)
2010  
15
The clinical effectiveness and cost-effectiveness of topotecan for small cell lung cancer: a systematic review and economic evaluation.
[20356561] Health Technol Assess 14(19): 1-204 (2010)
2009  
16
Erlotinib for the treatment of relapsed non-small cell lung cancer.
[19567213] Health Technol Assess 13 Suppl 1(-): 41-7 (2009)
2006  
17
The clinical effectiveness and cost-effectiveness of computed tomography screening for lung cancer: systematic reviews.
[16409881] Health Technol Assess 10(3): iii-iv, ix-x, 1-90 (2006)
1958  
18
The solitary pulmonary nodule; a review of 236 consecutive cases, 1944 to 1956.
[13498640] Ann Surg 147(2): 197-202 (1958)
2008  
19
First- and second-line treatment of advanced metastatic non-small-cell lung cancer: a global view.
[18831719] BMC Proc 2 Suppl 2(-): S3 (2008)
2001  
20
Prophylactic cranial irradiation in small cell lung cancer: a systematic review of the literature with meta-analysis.
[11432756] BMC Cancer 1(-): 5 (2001)
2010  
21
Systemic therapies in metastatic non-small-cell lung cancer with emphasis on targeted therapies: the rational approach.
[20404973] Curr Oncol 17(2): 13-23 (2010)
2010  
22
Impact of biomarkers on non-small cell lung cancer treatment.
[20443070] Target Oncol 5(1): 5-17 (2010)
2009  
23
Anatomy, biology and concepts, pertaining to lung cancer stage classification.
[19333070] J Thorac Oncol 4(4): 437-43 (2009)
2009  
24
Preinvasive lesions of the bronchus.
[19279508] J Thorac Oncol 4(4): 545-51 (2009)
2008  
25
Turning gray: the natural history of lung cancer over time.
[18594326] J Thorac Oncol 3(7): 781-92 (2008)
2008  
26
EGFR inhibitors as first-line therapy in advanced non-small cell lung cancer.
[18317074] J Thorac Oncol 3(3): 303-10 (2008)
2007  
27
Chemotherapy for relapsed small cell lung cancer: a systematic review and practice guideline.
[17409809] J Thorac Oncol 2(4): 348-54 (2007)
2007  
28
A translational view of the molecular pathogenesis of lung cancer.
[17409807] J Thorac Oncol 2(4): 327-43 (2007)
2006  
29
A review of first-line treatment for small-cell lung cancer.
[17409868] J Thorac Oncol 1(3): 270-8 (2006)
2008  
30
Small-cell lung cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up.
[18456763] Ann Oncol 19 Suppl 2(-): ii41-2 (2008)
2008  
31
Non-small-cell lung cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up.
[18456762] Ann Oncol 19 Suppl 2(-): ii39-40 (2008)
2006  
32
The expanding role of systemic treatment in non-small cell lung cancer neo-adjuvant therapy.
[17018710] Ann Oncol 17 Suppl 10(-): x108-12 (2006)
2006  
33
Expanding role of chemotherapy in lung cancer.
[17018709] Ann Oncol 17 Suppl 10(-): x101-7 (2006)
2006  
34
Second-line chemotherapy for non-small cell lung cancer.
[16807467] Ann Oncol 17 Suppl 5(-): v68-71 (2006)
2006  
35
First line chemotherapy in advanced or metastatic NSCLC.
[16807466] Ann Oncol 17 Suppl 5(-): v64-7 (2006)
2006  
36
Current status of adjuvant chemotherapy in NSCLC.
[16807465] Ann Oncol 17 Suppl 5(-): v62-3 (2006)
2006  
37
Neo-adjuvant chemotherapy in non-small cell lung cancer (NSCLC).
[16807464] Ann Oncol 17 Suppl 5(-): v55-61 (2006)
2006  
38
Chemo-radiotherapy in non-small cell lung cancer: the role of gemcitabine.
[16807463] Ann Oncol 17 Suppl 5(-): v52-4 (2006)
2006  
39
Development of gemcitabine in non-small cell lung cancer: the Italian contribution.
[16807461] Ann Oncol 17 Suppl 5(-): v37-46 (2006)
2006  
40
10-year update on chemotherapy for non-small cell lung cancer.
[16807460] Ann Oncol 17 Suppl 5(-): v33-36 (2006)
2006  
41
Clinical studies of pemetrexed and gemcitabine combinations.
[16807459] Ann Oncol 17 Suppl 5(-): v29-32 (2006)
2006  
42
Prophylactic cranial irradiation in non-small cell lung cancer.
[16608992] Ann Oncol 17 Suppl 2(-): ii76-78 (2006)
2006  
43
Brain metastases in patients with non-small cell lung cancer: focus on the role of chemotherapy.
[16608991] Ann Oncol 17 Suppl 2(-): ii73-75 (2006)
2006  
44
Treatment and prophylaxis for brain metastases from non-small cell lung cancer: whole brain radiation treatment versus stereotactic radiosurgery.
[16608990] Ann Oncol 17 Suppl 2(-): ii71-72 (2006)
2006  
45
Maintenance chemotherapy in non-small cell lung cancer.
[16608989] Ann Oncol 17 Suppl 2(-): ii67-70 (2006)
2006  
46
2006  
47
Treatment of advanced non-small cell lung cancer.
[16608979] Ann Oncol 17 Suppl 2(-): ii36-41 (2006)
2006  
48
New radiation techniques for treatment of locally advanced non-small cell lung cancer (NSCLC).
[16608978] Ann Oncol 17 Suppl 2(-): ii34-35 (2006)
2002  
49
Patterns of failure after prophylactic cranial irradiation in small-cell lung cancer: analysis of 505 randomized patients.
[12075744] Ann Oncol 13(5): 748-54 (2002)
2008  
50
Pneumonectomy after chemoradiation: the Dana-Farber Cancer Institute/Brigham and Women's Hospital experience.
[18286507] Cancer 112(5): 1106-13 (2008)
2007  
51
Primary salivary gland-type lung cancer: spectrum of clinical presentation, histopathologic and prognostic factors.
[17918258] Cancer 110(10): 2253-9 (2007)
2007  
52
Recent improvement in the survival of patients with advanced nonsmall cell lung cancer enrolled in phase III trials of first-line, systemic chemotherapy.
[17285602] Cancer 109(5): 939-48 (2007)
2006  
53
Risk factors for local progression after percutaneous radiofrequency ablation of lung tumors: evaluation based on a preliminary review of 342 tumors.
[17096433] Cancer 107(12): 2873-80 (2006)
2000  
54
Multiple chondromatous hamartomas of the lung: a case report and review of the literature with special reference to Carney syndrome.
[10679667] Cancer 88(4): 964-5 (2000)
2007  
55
Adjuvant chemotherapy in elderly patients with non-small-cell lung cancer.
[17242671] Cancer Control 14(1): 57-62 (2007)
2006  
56
Large-cell neuroendocrine carcinoma of the lung.
[17075564] Cancer Control 13(4): 270-5 (2006)
2006  
57
Solitary fibrous tumor of the pleura.
[17075563] Cancer Control 13(4): 264-9 (2006)
2006  
58
Understanding the uncommon thoracic tumors.
[17075561] Cancer Control 13(4): 252-3 (2006)
2001  
59
2001  
60
2001  
61
Treatment of advanced non-small-cell lung cancer: a review of current randomized clinical trials and an examination of emerging therapies.
[11483886] Cancer Control 8(4): 326-36 (2001)
2001  
62
Early detection of lung cancer: clinical perspectives of recent advances in biology and radiology.
[11205917] Clin Cancer Res 7(1): 5-22 (2001)
1998  
63
New chemotherapeutic agents prolong survival and improve quality of life in non-small cell lung cancer: a review of the literature and future directions.
[9607565] Clin Cancer Res 4(5): 1087-100 (1998)
1997  
64
Combined modality therapy of lung cancer.
[10068267] Clin Cancer Res 3(12 Pt 2): 2638-47 (1997)
2007  
65
18Fluorodeoxyglucose positron emission tomography in the diagnosis and staging of lung cancer: a systematic review.
[18042932] J Natl Cancer Inst 99(23): 1753-67 (2007)
2007  
66
Cisplatin- versus carboplatin-based chemotherapy in first-line treatment of advanced non-small-cell lung cancer: an individual patient data meta-analysis.
[17551145] J Natl Cancer Inst 99(11): 847-57 (2007)
2007  
67
Cisplatin versus carboplatin for patients with metastatic non-small-cell lung cancer--an old rivalry renewed.
[17551137] J Natl Cancer Inst 99(11): 828-9 (2007)
2009  
68
The role of the taxanes in the treatment of older patients with advanced stage non-small cell lung cancer.
[19342473] Oncologist 14(4): 412-24 (2009)
2009  
69
The differential efficacy of pemetrexed according to NSCLC histology: a review of two Phase III studies.
[19221167] Oncologist 14(3): 253-63 (2009)
2008  
70
Consensus conference: multimodality management of early- and intermediate-stage non-small cell lung cancer.
[18779538] Oncologist 13(9): 945-53 (2008)
2008  
71
Critical review of nonsurgical treatment options for stage I non-small cell lung cancer.
[18378542] Oncologist 13(3): 309-19 (2008)
2008  
72
Considerations for second-line therapy of non-small cell lung cancer.
[18263772] Oncologist 13 Suppl 1(-): 28-36 (2008)
2008  
73
Local control of regional and metastatic lesions and indication for systemic chemotherapy in patients with non-small cell lung cancer.
[18263771] Oncologist 13 Suppl 1(-): 21-7 (2008)
2008  
74
Clinical evidence for second- and third-line treatment options in advanced non-small cell lung cancer.
[18263770] Oncologist 13 Suppl 1(-): 14-20 (2008)
2008  
75
Systemic chemotherapy for advanced non-small cell lung cancer: recent advances and future directions.
[18263769] Oncologist 13 Suppl 1(-): 5-13 (2008)
2008  
76
CT screening for lung cancer: update 2007.
[18245013] Oncologist 13(1): 65-78 (2008)
2007  
77
Recent advances with topotecan in the treatment of lung cancer.
[17962613] Oncologist 12(10): 1194-204 (2007)
2007  
78
The role of bevacizumab in the treatment of non-small cell lung cancer: current indications and future developments.
[17962612] Oncologist 12(10): 1183-93 (2007)
2007  
79
Erlotinib in non-small cell lung cancer treatment: current status and future development.
[17673615] Oncologist 12(7): 840-9 (2007)
2007  
80
Sequential, alternating, and maintenance/consolidation chemotherapy in advanced non-small cell lung cancer: a review of the literature.
[17470688] Oncologist 12(4): 451-64 (2007)
2006  
81
Combined modality therapy for stage III non-small cell lung cancer.
[16880240] Oncologist 11(7): 809-23 (2006)
2006  
82
Salvage therapy for advanced non-small cell lung cancer: factors influencing treatment selection.
[16794244] Oncologist 11(6): 655-65 (2006)
2005  
83
Treatment of small cell lung cancer in the elderly.
[15967834] Oncologist 10(6): 399-411 (2005)
2001  
84
2000  
85
Prophylactic cranial irradiation in small-cell lung cancer.
[10964996] Oncologist 5(4): 293-8 (2000)
2008  
86
Second-line and third-line chemotherapy for lung cancer: use and cost.
[18471034] Am J Manag Care 14(5): 297-306 (2008)
2004  
87
Lung cancer screening with sputum cytologic examination, chest radiography, and computed tomography: an update for the U.S. Preventive Services Task Force.
[15126259] Ann Intern Med 140(9): 740-53 (2004)
2004  
88
Lung cancer screening: recommendation statement.
[15126258] Ann Intern Med 140(9): 738-9 (2004)
2009  
89
A translational approach to lung cancer research: From EGFRs to Wnt and cancer stem cells.
[19763051] Ann Thorac Cardiovasc Surg 15(4): 213-20 (2009)
2008  
90
2007  
91
Management of small cell lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition).
[17873178] Chest 132(3 Suppl): 324S-339S (2007)
2007  
92
Evidence for management of small cell lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition).
[17873177] Chest 132(3 Suppl): 314S-323S (2007)
2007  
93
Bronchioloalveolar lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition).
[17873176] Chest 132(3 Suppl): 306S-13S (2007)
2007  
94
Special treatment issues in lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition).
[17873175] Chest 132(3 Suppl): 290S-305S (2007)
2007  
95
Treatment of non-small cell lung cancer, stage IV: ACCP evidence-based clinical practice guidelines (2nd edition).
[17873174] Chest 132(3 Suppl): 277S-289S (2007)
2007  
96
Treatment of non-small cell lung cancer, stage IIIB: ACCP evidence-based clinical practice guidelines (2nd edition).
[17873173] Chest 132(3 Suppl): 266S-276S (2007)
2007  
97
Treatment of non-small cell lung cancer-stage IIIA: ACCP evidence-based clinical practice guidelines (2nd edition).
[17873172] Chest 132(3 Suppl): 243S-265S (2007)
2007  
98
Treatment of non-small cell lung cancer stage I and stage II: ACCP evidence-based clinical practice guidelines (2nd edition).
[17873171] Chest 132(3 Suppl): 234S-242S (2007)
2007  
99
Bronchial intraepithelial neoplasia/early central airways lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition).
[17873170] Chest 132(3 Suppl): 221S-233S (2007)
2007  
100
Invasive mediastinal staging of lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition).
[17873169] Chest 132(3 Suppl): 202S-220S (2007)
2007  
101
Noninvasive staging of non-small cell lung cancer: ACCP evidenced-based clinical practice guidelines (2nd edition).
[17873168] Chest 132(3 Suppl): 178S-201S (2007)
2007  
102
Physiologic evaluation of the patient with lung cancer being considered for resectional surgery: ACCP evidenced-based clinical practice guidelines (2nd edition).
[17873167] Chest 132(3 Suppl): 161S-77S (2007)
2007  
103
Initial evaluation of the patient with lung cancer: symptoms, signs, laboratory tests, and paraneoplastic syndromes: ACCP evidenced-based clinical practice guidelines (2nd edition).
[17873166] Chest 132(3 Suppl): 149S-160S (2007)
2007  
104
Initial diagnosis of lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition).
[17873165] Chest 132(3 Suppl): 131S-148S (2007)
2007  
105
Evaluation of patients with pulmonary nodules: when is it lung cancer?: ACCP evidence-based clinical practice guidelines (2nd edition).
[17873164] Chest 132(3 Suppl): 108S-130S (2007)
2007  
106
Evidence for the treatment of patients with pulmonary nodules: when is it lung cancer?: ACCP evidence-based clinical practice guidelines (2nd edition).
[17873163] Chest 132(3 Suppl): 94S-107S (2007)
2007  
107
Diagnostic surgical pathology in lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition).
[17873162] Chest 132(3 Suppl): 78S-93S (2007)
2007  
108
Screening for lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition).
[17873161] Chest 132(3 Suppl): 69S-77S (2007)
2006  
109
Long-term survivorship in lung cancer: a review.
[16608961] Chest 129(4): 1088-97 (2006)
2004  
110
Malignant pleural mesothelioma: update, current management, and newer therapeutic strategies.
[15486399] Chest 126(4): 1318-29 (2004)
2003  
111
Surgical treatment of malignant pleural mesothelioma: a review.
[12576380] Chest 123(2): 551-61 (2003)
2003  
112
Initial evaluation of the patient with lung cancer: symptoms, signs, laboratory tests, and paraneoplastic syndromes.
[12527569] Chest 123(1 Suppl): 97S-104S (2003)
2000  
113
Diagnosis of lung cancer: pathology of invasive and preinvasive neoplasia.
[10777460] Chest 117(4 Suppl 1): 80S-89S (2000)
1999  
114
Advances in the treatment of malignant pleural mesothelioma.
[10453882] Chest 116(2): 504-20 (1999)
1998  
115
Bronchoalveolar carcinoma: histopathologic study of evolution in a series of 105 surgically treated patients.
[9498957] Chest 113(2): 391-5 (1998)
1993  
116
Natural history and epidemiology of malignant mesothelioma.
[8462328] Chest 103(4 Suppl): 373S-376S (1993)
2002  
117
Diagnostic imaging of lung cancer.
[11999004] Eur Respir J 19(4): 722-42 (2002)
2001  
118
The new World Health Organization classification of lung tumours.
[11829087] Eur Respir J 18(6): 1059-68 (2001)
1998  
119
Pulmonary epithelioid haemangioendothelioma in 21 patients, including three with partial spontaneous regression.
[9701420] Eur Respir J 12(1): 89-96 (1998)
1995  
120
Biological and immunological aspects of malignant mesothelioma.
[7664867] Eur Respir J 8(4): 643-50 (1995)
1994  
121
Serum tumour markers in lung cancer: history, biology and clinical applications.
[8143820] Eur Respir J 7(1): 186-97 (1994)
2007  
122
New molecularly targeted therapies for lung cancer.
[17909619] J Clin Invest 117(10): 2740-50 (2007)
2006  
123
Immunohistochemical markers of prognosis in non-small cell lung cancer: a review and proposal for a multiphase approach to marker evaluation.
[16873561] J Clin Pathol 59(8): 790-800 (2006)
1987  
124
Pulmonary adenocarcinoma: review of 106 cases and proposed new classification.
[3818979] J Clin Pathol 40(2): 125-35 (1987)
2008  
125
Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship.
[18452692] Mayo Clin Proc 83(5): 584-94 (2008)
2008  
126
2009  
127
Current treatments for advanced stage non-small cell lung cancer.
[19349493] Proc Am Thorac Soc 6(2): 233-41 (2009)
2009  
128
Adjuvant treatment of resected lung cancer.
[19349488] Proc Am Thorac Soc 6(2): 194-200 (2009)
2002  
129
Preneoplastic lesions of the lung.
[11980589] Respir Res 3(-): 20 (2002)
1987  
130
Mesenchymoma of the lung (so called hamartoma): a review of 154 parenchymal and endobronchial cases.
[3321538] Thorax 42(10): 790-3 (1987)
1984  
131
Alveolar carcinoma: a review.
[6324408] Thorax 39(3): 166-74 (1984)
1984  
132
Histological classification of lung cancer.
[6324407] Thorax 39(3): 161-5 (1984)
1982  
133
Diffuse malignant mesothelioma: a review.
[6761970] West J Med 137(6): 548-54 (1982)
2007  
134
Pictorial review of the many faces of bronchioloalveolar cell carcinoma.
[17940131] Br J Radiol 80(960): 1015-23 (2007)
2001  
135
2008  
136
Pulmonary nodules: detection, assessment, and CAD.
[18806142] AJR Am J Roentgenol 191(4): 1057-69 (2008)
2008  
137
2007  
138
Solitary pulmonary nodules: detection, characterization, and guidance for further diagnostic workup and treatment.
[17179346] AJR Am J Roentgenol 188(1): 57-68 (2007)
2005  
139
Detection of pulmonary nodules using a 2D HASTE MR sequence: comparison with MDCT.
[16177419] AJR Am J Roentgenol 185(4): 979-84 (2005)
1994  
140
Lymphoproliferative disorders of the lung: histopathology, clinical manifestations, and imaging features.
[8037014] AJR Am J Roentgenol 163(2): 273-81 (1994)
1992  
141
Malignant pleural mesothelioma: value of CT and MR imaging in predicting resectability.
[1414807] AJR Am J Roentgenol 159(5): 961-6 (1992)
1990  
142
Pitfalls in the radiologic diagnosis of lung cancer.
[2110722] AJR Am J Roentgenol 154(6): 1165-75 (1990)
1990  
143
Radiologic evaluation of the solitary pulmonary nodule.
[2107661] AJR Am J Roentgenol 154(4): 701-8 (1990)
1983  
144
Leiomyomatous lung lesions: a proposed classification.
[6603116] AJR Am J Roentgenol 141(2): 269-72 (1983)
1977  
145
1976 Caldwell Lecture: varying manifestation of peripheral pulmonary neoplasms: a radiologic-pathologic correlative study.
[414553] AJR Am J Roentgenol 128(6): 893-914 (1977)
1976  
146
Pulmonary blastoma: case report and literature review.
[998819] AJR Am J Roentgenol 127(6): 1048-9 (1976)
2005  
147
Utility of 18F-FDG PET in evaluating cancers of lung.
[15930019] J Nucl Med Technol 33(2): 69-74; quiz 75-7 (2005)
2009  
148
Cost-effectiveness of 99mTc-sestamibi in predicting response to chemotherapy in patients with lung cancer: systematic review and meta-analysis.
[19223414] J Nucl Med 50(3): 376-81 (2009)
1999  
149
2006  
150
From the archives of the AFIP: Pleuropulmonary synovial sarcoma.
[16702463] Radiographics 26(3): 923-40 (2006)
2002  
151
Unusual primary lung tumors: a radiologic-pathologic overview.
[12006690] Radiographics 22(3): 601-19 (2002)
2001  
152
Oncodiagnosis panel: 1999. Cancer of the lung: oncodiagnosis.
[11706227] Radiographics 21(6): 1573-96 (2001)
1997  
153
Bronchioloalveolar carcinoma: clinical, histopathologic, and radiologic findings.
[9397450] Radiographics 17(6): 1345-57 (1997)
1994  
154
Bronchogenic carcinoma: radiologic-pathologic correlation.
[8190965] Radiographics 14(2): 429-46; quiz 447-8 (1994)
1992  
155
CT of focal pulmonary masses in childhood.
[1609141] Radiographics 12(3): 505-14 (1992)
2005  
156
Case report: pulmonary blastoma: presentation of two atypical cases and review of the literature.
[15845939] Br J Radiol 78(929): 437-40 (2005)
2005  
157
Imaging of the patient with non-small cell lung cancer.
[16251391] Radiology 237(3): 803-18 (2005)
2005  
158
Guidelines for management of small pulmonary nodules detected on CT scans: a statement from the Fleischner Society.
[16244247] Radiology 237(2): 395-400 (2005)
2005  
159
Peripheral solitary pulmonary nodule: CT findings in patients with pulmonary emphysema.
[15716392] Radiology 235(1): 266-73 (2005)
2008  
160
Molecular diagnosis of lung cancer: an overview of recent developments.
[18924306] Acta Biomed 79 Suppl 1(-): 11-23 (2008)
2002  
161
Interventional palliative treatment options for lung cancer.
[12401697] Ann Oncol 13 Suppl 4(-): 247-50 (2002)
2010  
162
Early stage and locally advanced (non-metastatic) non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
[20555058] Ann Oncol 21 Suppl 5(-): v103-15 (2010)
2010  
163
Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
[20555059] Ann Oncol 21 Suppl 5(-): v116-9 (2010)
2010  
164
Small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
[20555060] Ann Oncol 21 Suppl 5(-): v120-5 (2010)
2010  
165
Adjuvant chemotherapy for resectable non-small-cell lung cancer: where is it going?
[20943614] Ann Oncol 21 Suppl 7(-): vii196-8 (2010)
2010  
166
Do we have markers to select patients for adjuvant therapies of non-small-cell lung cancer?
[20943615] Ann Oncol 21 Suppl 7(-): vii199-202 (2010)
2010  
167
Should we continue to use the term non-small-cell lung cancer?
[20943619] Ann Oncol 21 Suppl 7(-): vii225-9 (2010)
2010  
168
How to integrate current knowledge in selecting patients for first line in NSCLC?
[20943620] Ann Oncol 21 Suppl 7(-): vii230-3 (2010)
2010  
169
Consequences of targeted treatments for second-line therapy.
[20943621] Ann Oncol 21 Suppl 7(-): vii234-40 (2010)
2010  
170
Early stage non-small-cell lung cancer: challenges in staging and adjuvant treatment: evidence-based staging.
[20943613] Ann Oncol 21 Suppl 7(-): vii189-95 (2010)
2009  
171
Non-small-cell lung cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up.
[19454467] Ann Oncol 20 Suppl 4(-): 68-70 (2009)
2009  
172
Small-cell lung cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up.
[19454469] Ann Oncol 20 Suppl 4(-): 71-2 (2009)
2010  
173
Second-line treatments of advanced non-small-cell lung cancer: new evidence for clinical practice.
[19920059] Ann Oncol 21(2): 428-9 (2010)
2010  
174
New Response Evaluation Criteria in Solid Tumors (RECIST) guidelines for advanced non-small cell lung cancer: comparison with original RECIST and impact on assessment of tumor response to targeted therapy.
[20729419] AJR Am J Roentgenol 195(3): W221-8 (2010)
2010  
175
A radiologic review of the new TNM classification for lung cancer.
[20173129] AJR Am J Roentgenol 194(3): 562-73 (2010)
2010  
176
Multiple cystlike lung lesions in the adult.
[20028879] AJR Am J Roentgenol 194(1): W1-W11 (2010)
2009  
177
Staging of non-small cell lung cancer using integrated PET/CT.
[19843732] AJR Am J Roentgenol 193(5): 1203-11 (2009)
2008  
178
Imaging of non-small cell lung cancer of the superior sulcus: part 1: anatomy, clinical manifestations, and management.
[18349457] Radiographics 28(2): 551-60; quiz 620 (2008)
2008  
179
Imaging of non-small cell lung cancer of the superior sulcus: part 2: initial staging and assessment of resectability and therapeutic response.
[18349458] Radiographics 28(2): 561-72 (2008)
2011  
180
SEPAR guidelines for lung cancer staging.
[21824707] Arch Bronconeumol 47(9): 454-65 (2011)
2011  
181
Primary pulmonary mucinous cystadenocarcinoma: presentation of a case and a review of the literature.
[21439701] Arch Bronconeumol 47(4): 216-7 (2011)
2004  
182
The diagnosis of bronchioloalveolar carcinoma by cytologic means.
[15272525] Am J Clin Pathol 122(1): 14-6 (2004)
2009  
183
Micropapillary histology: a frequent morphology of mutation-associated lung adenocarcinoma?
[19369618] Am J Clin Pathol 131(5): 615-7 (2009)
2005  
184
The spectrum of pulmonary mucinous cystic neoplasia : a clinicopathologic and immunohistochemical study of ten cases and review of literature.
[15923171] Am J Clin Pathol 124(1): 62-70 (2005)
2011  
185
A systemic review of PET and biology in lung cancer.
[21904658] Am J Transl Res 3(4): 383-91 (2011)
2007  
186
Computed tomography screening for lung cancer.
[17289689] BMJ 334(7588): 271 (2007)
2010  
187
Novel insights into the molecular origins and treatment of lung cancer.
[20962595] Cell Cycle 9(20): 4098-105 (2010)
2004  
188
Pulmonary epithelioid hemangioendothelioma: an unusual case and a review of the literature.
[14769767] Chest 125(2): 789-93 (2004)
2003  
189
Lung cancer. Special treatment issues.
[12527583] Chest 123(1 Suppl): 244S-258S (2003)
2003  
190
2010  
191
PET scans for lung nodules: costs and cost-effectiveness.
[20051397] Chest 137(1): 4-6 (2010)
2007  
192
Complementary therapies and integrative oncology in lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition).
[17873179] Chest 132(3 Suppl): 340S-354S (2007)
2007  
193
Follow-up and surveillance of the lung cancer patient following curative intent therapy: ACCP evidence-based clinical practice guideline (2nd edition).
[17873180] Chest 132(3 Suppl): 355S-367S (2007)
2009  
194
The new lung cancer staging system.
[19584208] Chest 136(1): 260-71 (2009)
2004  
195
Malignant versus benign nodules at CT screening for lung cancer: comparison of thin-section CT findings.
[15498895] Radiology 233(3): 793-8 (2004)
2009  
196
Subsolid pulmonary nodules and the spectrum of peripheral adenocarcinomas of the lung: recommended interim guidelines for assessment and management.
[19952025] Radiology 253(3): 606-22 (2009)
2007  
197
Clinical predictors of metastatic disease to the brain from non-small cell lung carcinoma: primary tumor size, cell type, and lymph node metastases.
[17229875] Radiology 242(3): 882-8 (2007)
2009  
198
Pulmonary nodules: volume repeatability at multidetector CT lung cancer screening.
[19380692] Radiology 251(3): 919-25 (2009)
2009  
199
Noncalcified lung nodules: volumetric assessment with thoracic CT.
[19332844] Radiology 251(1): 26-37 (2009)
2008  
200
Microwave ablation of lung malignancies: effectiveness, CT findings, and safety in 50 patients.
[18372457] Radiology 247(3): 871-9 (2008)
2008  
201
Comparison of chest tomosynthesis and chest radiography for detection of pulmonary nodules: human observer study of clinical cases.
[18849504] Radiology 249(3): 1034-41 (2008)
2008  
202
Estimating long-term effectiveness of lung cancer screening in the Mayo CT screening study.
[18458247] Radiology 248(1): 278-87 (2008)
2011  
203
The role of proteasome inhibition in nonsmall cell lung cancer.
[21629760] J Biomed Biotechnol 2011(-): 806506 (2011)
2011  
204
2009  
205
2005  
206
What are the clinical features of lung cancer before the diagnosis is made? A population based case-control study.
[16227326] Thorax 60(12): 1059-65 (2005)
2003  
207
Lung cancer . 3: Fluorescence bronchoscopy: clinical dilemmas and research opportunities.
[12612310] Thorax 58(3): 266-71 (2003)
2007  
208
Photodynamic therapy (PDT) in early central lung cancer: a treatment option for patients ineligible for surgical resection.
[17090572] Thorax 62(5): 391-5 (2007)
2007  
209
Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia: an under-recognised spectrum of disease.
[17099078] Thorax 62(3): 248-52 (2007)
2011  
210
Approach to multiple pulmonary nodules: a case report and review of literature.
[21479348] ScientificWorldJournal 11(-): 760-5 (2011)
2010  
211
Rare causes of calcitriol-mediated hypercalcemia: a case report and literature review.
[20427501] J Clin Endocrinol Metab 95(7): 3111-7 (2010)
2010  
212
Gefitinib or erlotinib in the treatment of advanced non-small cell lung cancer.
[20587343] Discov Med 9(49): 538-45 (2010)
2011  
213
Role of Survival Post-Progression in Phase III Trials of Systemic Chemotherapy in Advanced Non-Small-Cell Lung Cancer: A Systematic Review.
[22114662] PLoS One 6(11): e26646 (2011)
2011  
214
Addition of bevacizumab to chemotherapy in advanced non-small cell lung cancer: a systematic review and meta-analysis.
[21829644] PLoS One 6(8): e22681 (2011)
2007  
215
The role of phosphoinositide 3-kinase pathway inhibitors in the treatment of lung cancer.
[17671156] Clin Cancer Res 13(15 Pt 2): s4637-40 (2007)
2007  
216
HKI-272 in non small cell lung cancer.
[17671147] Clin Cancer Res 13(15 Pt 2): s4593-6 (2007)
2007  
217
Antibodies to the epidermal growth factor receptor in non small cell lung cancer: current status of matuzumab and panitumumab.
[17671148] Clin Cancer Res 13(15 Pt 2): s4597-601 (2007)
2009  
218
Baseline vascular endothelial growth factor concentration as a potential predictive marker of benefit from vandetanib in non-small cell lung cancer.
[19447868] Clin Cancer Res 15(10): 3600-9 (2009)
2009  
219
Combined survival analysis of prospective clinical trials of gefitinib for non-small cell lung cancer with EGFR mutations.
[19531624] Clin Cancer Res 15(13): 4493-8 (2009)
2009  
220
Epidermal growth factor receptor inhibitors and antiangiogenic agents for the treatment of non-small cell lung cancer.
[19671872] Clin Cancer Res 15(16): 5040-8 (2009)
2009  
221
Lung cancer in never smokers: molecular profiles and therapeutic implications.
[19755392] Clin Cancer Res 15(18): 5646-61 (2009)
2009  
222
Lung cancer in never smokers: clinical epidemiology and environmental risk factors.
[19755391] Clin Cancer Res 15(18): 5626-45 (2009)
2006  
223
2010  
224
Adjuvant therapy in non-small cell lung cancer: current and future directions.
[20682608] Oncologist 15(8): 862-72 (2010)
2010  
225
Maintenance and consolidation therapy in patients with unresectable stage III/IV non-small cell lung cancer.
[20930098] Oncologist 15(10): 1034-42 (2010)
2010  
226
Histology matters: individualizing treatment in non-small cell lung cancer.
[20086166] Oncologist 15(1): 3-5 (2010)
2010  
227
Limited-stage small cell lung cancer: current chemoradiotherapy treatment paradigms.
[20145192] Oncologist 15(2): 187-95 (2010)
2010  
228
Do we have enough evidence to implement particle therapy as standard treatment in lung cancer? A systematic literature review.
[20067947] Oncologist 15(1): 93-103 (2010)
2007  
229
Indications and developments of video-assisted thoracic surgery in the treatment of lung cancer.
[17962614] Oncologist 12(10): 1205-14 (2007)
2007  
230
Second-generation epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer.
[17405897] Oncologist 12(3): 325-30 (2007)
2007  
231
Increasing chemotherapy in small-cell lung cancer: from dose intensity and density to megadoses.
[17227903] Oncologist 12(1): 79-89 (2007)
2005  
232
Three emerging new drugs for NSCLC: pemetrexed, bortezomib, and cetuximab.
[15821248] Oncologist 10(4): 282-91 (2005)
2009  
233
Combined inhibition of the VEGFR and EGFR signaling pathways in the treatment of NSCLC.
[19357226] Oncologist 14(4): 399-411 (2009)
2009  
234
Vascular disrupting agents: a novel mechanism of action in the battle against non-small cell lung cancer.
[19474164] Oncologist 14(6): 612-20 (2009)
2009  
235
Cetuximab and other anti-epidermal growth factor receptor monoclonal antibodies in the treatment of non-small cell lung cancer.
[19482958] Oncologist 14(6): 601-11 (2009)
2009  
236
The role of EGFR inhibition in the treatment of non-small cell lung cancer.
[19892771] Oncologist 14(11): 1116-30 (2009)
2009  
237
Pulmonary neuroendocrine/carcinoid tumors: a review article.
[19562772] Cancer 115(19): 4434-41 (2009)
2008  
238
LKB1 and lung cancer: more than the usual suspects.
[18483235] Cancer Res 68(10): 3562-5 (2008)
2006  
239
Vinflunine -- an active chemotherapy for treatment of advanced non-small-cell lung cancer previously treated with a platinum-based regimen: results of a phase II study.
[16641911] Br J Cancer 94(10): 1383-8 (2006)
2010  
240
Phase II study of nedaplatin and irinotecan with concurrent thoracic radiotherapy in patients with locally advanced non-small-cell lung cancer.
[20940720] Br J Cancer 103(9): 1325-30 (2010)
2004  
241
The epidemiology of interstitial lung disease and its association with lung cancer.
[15340372] Br J Cancer 91 Suppl 2(-): S3-10 (2004)
2007  
242
How to evaluate the risk/benefit of trimodality therapy in locally advanced non-small-cell lung cancer.
[17473830] Br J Cancer 96(10): 1498-503 (2007)
2010  
243
Update in lung cancer and mesothelioma 2009.
[20382800] Am J Respir Crit Care Med 181(8): 773-81 (2010)
2011  
244
The morphological and molecular diagnosis of lung cancer.
[21886665] Dtsch Arztebl Int 108(31-32): 525-31 (2011)
2010  
245
Pemetrexed for the maintenance treatment of locally advanced or metastatic non-small cell lung cancer.
[21047489] Health Technol Assess 14(Suppl. 2): 33-9 (2010)
2010  
246
Gefitinib for the first-line treatment of locally advanced or metastatic non-small cell lung cancer.
[21047494] Health Technol Assess 14(Suppl. 2): 71-9 (2010)
2010  
247
Pemetrexed for the first-line treatment of locally advanced or metastatic non-small cell lung cancer.
[20507803] Health Technol Assess 14 Suppl 1(-): 47-53 (2010)
2010  
248
Recent development of molecular-targeted drugs in lung cancer.
[20847494] Intern Med 49(18): 1923-34 (2010)
2008  
249
Clinical relevance of sputum cytology and chest X-ray in patients with suspected lung tumors.
[18591840] Intern Med 47(13): 1199-205 (2008)
2011  
250
Diagnostic value of tumor marker pro-gastrin-releasing peptide in patients with small cell lung cancer: a systematic review.
[21740817] Chin Med J (Engl) 124(10): 1563-8 (2011)
2004  
251
Central nervous system metastases of a pulmonary epitheloid haemangioendothelioma.
[15065842] Eur Respir J 23(3): 483-6 (2004)
2009  
252
Differential diagnosis and management of focal ground-glass opacities.
[19047318] Eur Respir J 33(4): 821-7 (2009)
2009  
253
First- and second-line therapy for advanced nonsmall cell lung cancer.
[19336594] Eur Respir J 33(4): 915-30 (2009)
2005  
254
Reconstruction of chest wall defects after resection of large neoplasms: ten-year experience.
[17670403] Interact Cardiovasc Thorac Surg 4(3): 250-5 (2005)
2010  
255
2009  
256
Role of immunohistochemistry in the diagnosis of lung cancer.
[19466276] J Bras Pneumol 35(4): 375-82 (2009)
2008  
257
Histological diagnosis of lung cancer micrometastases.
[18392459] J Bras Pneumol 34(3): 127-8 (2008)
2007  
258
Staging non-small cell lung cancer.
[17964957] Cancer Imaging 7(-): 148-59 (2007)
2008  
259
Radiofrequency ablation of pulmonary tumours: current status.
[18331970] Cancer Imaging 8(-): 27-35 (2008)
2008  
260
Lung tumour ablation - where are we now?
[18442957] Cancer Imaging 8(-): 116-7 (2008)
2006  
261
Unusual lung tumours: an illustrated review of CT features suggestive of this diagnosis.
[16829468] Cancer Imaging 6(-): 72-82 (2006)
2003  
262
Image-guided conformal radiation therapy planning and delivery for non-small-cell lung cancer.
[12915806] Cancer Control 10(4): 277-88 (2003)
2003  
263
New approaches for small-cell lung cancer: local treatments.
[12915807] Cancer Control 10(4): 289-96 (2003)
2003  
264
Nucleotide excision repair pathways involved in Cisplatin resistance in non-small-cell lung cancer.
[12915808] Cancer Control 10(4): 297-305 (2003)
2003  
265
A systematic review and lessons learned from early lung cancer detection trials using low-dose computed tomography of the chest.
[12915809] Cancer Control 10(4): 306-14 (2003)
2008  
266
Functional lung imaging in thoracic cancer radiotherapy.
[18376378] Cancer Control 15(2): 112-9 (2008)
2004  
267
Position of nuclear medicine modalities in the diagnostic workup of cancer patients: lung cancer.
[15243408] Q J Nucl Med Mol Imaging 48(2): 119-42 (2004)
2010  
268
Advantages of breath testing for the early diagnosis of lung cancer.
[20370582] Expert Rev Mol Diagn 10(3): 255-7 (2010)
2009  
269
2010  
270
EGFR-mutated lung cancer: a paradigm of molecular oncology.
[21165163] Oncotarget 1(7): 497-514 (2010)
2009  
271
Role of 18F-FDG PET in assessment of response in non-small cell lung cancer.
[19380411] J Nucl Med 50 Suppl 1(-): 31S-42S (2009)
2009  
272
BRG1 and LKB1: tales of two tumor suppressor genes on chromosome 19p and lung cancer.
[19176640] Carcinogenesis 30(4): 547-54 (2009)
2010  
273
Gene therapy for mesothelioma and lung cancer.
[20160042] Am J Respir Cell Mol Biol 42(4): 385-93 (2010)
2010  
274
Asbestos, lung cancers, and mesotheliomas: from molecular approaches to targeting tumor survival pathways.
[20068227] Am J Respir Cell Mol Biol 42(2): 133-9 (2010)
2011  
275
Caspase 9b: a new target for therapy in non-small-cell lung cancer.
[21504315] Expert Rev Anticancer Ther 11(4): 499-502 (2011)
2004  
276
Bronchioloalveolar carcinoma in African Americans.
[15481747] J Natl Med Assoc 96(9): 1193-8 (2004)
2011  
277
Nontypeable Haemophilus influenzae in chronic obstructive pulmonary disease and lung cancer.
[21407824] Int J Chron Obstruct Pulmon Dis 6(-): 113-23 (2011)
2010  
278
Tumors in the lung--morphologic features and the challenge of integrating biomarker signatures into diagnostics.
[21103615] Rom J Morphol Embryol 51(4): 607-14 (2010)
2009  
279
Optimizing the management of advanced non-small-cell lung cancer: a personal view.
[19672420] Curr Oncol 16(4): 9-21 (2009)
2008  
280
Immunohistochemistry for assessment of pulmonary and pleural neoplasms: a review and update.
[18784820] Int J Clin Exp Pathol 1(1): 19-31 (2008)
2005  
281
The current status of sentinel lymph node mapping in non-small cell lung cancer.
[15900235] Ann Thorac Cardiovasc Surg 11(2): 67-72 (2005)
2011  
282
The epithelial cell and lung cancer: the link between chronic obstructive pulmonary disease and lung cancer.
[21311210] Respiration 81(2): 89-104 (2011)
2011  
283
Chronic obstructive pulmonary disease and lung cancer: new molecular insights.
[21430413] Respiration 81(4): 265-84 (2011)
2011  
284
The role of transcervical extended mediastinal lymphadenectomy for lung cancer staging.
[22029462] Expert Rev Med Devices 8(6): 665-7 (2011)
2011  
285
Tumor suppressors and cell-cycle proteins in lung cancer.
[22007345] Patholog Res Int 2011(-): 605042 (2011)
2011  
286
Advances in fine needle aspiration cytology for the diagnosis of pulmonary carcinoma.
[21776344] Patholog Res Int 2011(-): 897292 (2011)
2008  
287
Complications after lung radiofrequency ablation: risk factors for lung inflammation.
[18208852] Br J Radiol 81(963): 244-9 (2008)
2010  
288
Tumor and host factors that may limit efficacy of chemotherapy in non-small cell and small cell lung cancer.
[20047843] Crit Rev Oncol Hematol 75(3): 173-234 (2010)
2011  
289
2008  
290
Hereditary diffuse gastric cancer: association with lobular breast cancer.
[18046629] Fam Cancer 7(1): 73-82 (2008)
2010  
291
Endotoxin exposure and lung cancer risk: a systematic review and meta-analysis of the published literature on agriculture and cotton textile workers.
[20012774] Cancer Causes Control 21(4): 523-55 (2010)
2011  
292
Molecular profiles of EGFR, K-ras, c-met, and FGFR in pulmonary pleomorphic carcinoma, a rare lung malignancy.
[21626008] J Cancer Res Clin Oncol 137(8): 1203-11 (2011)
2009  
293
IGF-I and IGFBP-3 and the risk of lung cancer: a meta-analysis based on nested case-control studies.
[19549343] J Exp Clin Cancer Res 28(-): 89 (2009)
2010  
294
CyberKnife stereotactic ablative radiotherapy for lung tumors.
[21070081] Technol Cancer Res Treat 9(6): 589-96 (2010)
PMC   
295
Evaluation of video-assisted thoracoscopic surgery for pulmonary metastases: a meta-analysis.
[24416392] PLoS One 9(1):e85329 (2014)
PMC   
296
American Cancer Society lung cancer screening guidelines.
[23315954] CA Cancer J Clin 63(2):107-17 (2013)
PMC   
297
Diesel exhaust exposure and the risk of lung cancer-a review of the epidemiological evidence.
[24473109] Int J Environ Res Public Health 11(2):1312-40 (2014)
PMC   
298
Computed tomography screening for lung cancer: has it finally arrived? Implications of the national lung screening trial.
[23401434] J Clin Oncol 31(8):1002-8 (2013)
PMC   
299
Clinical characteristics and prognostic significance of 92 cases of patients with primary mixed-histology lung cancer.
[24649262] Mol Clin Oncol 1(5):863-868 (2013)
PMC   
300
Basal cell origins of smoking-induced airway epithelial disorders.
[24335435] Cell Cycle 13(3):341-2 (2014)
PMC   
301
Preoperative evaluation for lung cancer resection.
[24672690] J Thorac Dis 6(Suppl 1):S162-6 (2014)
PMC   
302
Pancoast tumors: characteristics and preoperative assessment.
[24672686] J Thorac Dis 6(Suppl 1):S108-15 (2014)
PMC   
303
Therapeutic modalities for Pancoast tumors.
[24672693] J Thorac Dis 6(Suppl 1):S180-93 (2014)
PMC   
304
Treatment of stage I lung cancer in high-risk and inoperable patients: SBRT vs. RFA vs. sublobar resection.
[24790840] Ann Cardiothorac Surg 3(2):167-9 (2014)
PMC   
305
Segmentectomy versus lobectomy for clinical stage IA lung adenocarcinoma.
[24790838] Ann Cardiothorac Surg 3(2):153-9 (2014)
PMC   
306
New techniques for assessing response after hypofractionated radiotherapy for lung cancer.
[24688782] J Thorac Dis 6(4):375-86 (2014)
PMC   
307
Imaging techniques for tumour delineation and heterogeneity quantification of lung cancer: overview of current possibilities.
[24688776] J Thorac Dis 6(4):319-27 (2014)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.


  • Lungenkarzinom - Prävention, Diagnostik, Therapie und Nachsorge


  • Search PubMed and many other databases on the combined search terms

    GG: lung cancer
    GG: sclc
    GG: nsclc

  • Lunge und Bronchialsystem (Neubildung)

  • The BDOM Bibliographic Dictionary of Medicine is a curated collection of free medical articles tagged to concepts.
    Contents until 2011 are reviews from PubMed, contents flagged 'PMC' are regular articles from PubMed Central.
    Search BDOM
    Nephrology Collection
    Radiology Locator

    PubMedCentral monthly collection of free medical articles by major subject

    The framed wikipedia articles are from en.wikipedia.org and they are the actual versions; the first is from Nephropedia